Skip to main content
SpringerLink
Log in

Safety Profile of Ranitidine

A Review

  • Review Article
  • Published:
Drugs Aims and scope Submit manuscript

Summary

Ranitidine has been used for the treatment of millions of patients during the past 10 years. A small proportion of patients have developed a reaction to the drug shortly after the start of treatment, usually as a result of ‘individual idiosyncrasy’. Reactions during continuous, long term treatment with ranitidine are uncommon, so that maintenance treatment of the chronic peptic diseases with ranitidine for more than 10 years has not been associated with significant iatrogenic disease.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  • Bachmann K, Sulli van TJ, Mauro LS, Martin M, Jauregui L, et al. Comparative investigation of the influence of nizatidine, ranitidine and cimetidine of the steady-state pharmacokinetics of theophylline in COPD patients. Journal of Clinical Pharmacology 32: 476–482, 1992

    Article  CAS  PubMed  Google Scholar 

  • Belaiche J. Consequences de la reduction de la secretion acide gastrique sur la secretion de facteur intrinsique et l’absorption des cobalamines. Gastroenterologie Clinique et Biologique 15: 1090–1150, 1991

    Google Scholar 

  • Berlin RG. Effects of H2-receptor antagonists on the central nervous system. Drug Development and Research 17: 97–108. 1989

    Article  CAS  Google Scholar 

  • Blum AL, Koelz HR, Armstrong D. Rezidivprophylaxe der Ulkuskrankheit: Indikation und Verfahrenswahl. Therapeutische Umschau 49: 761–775, 1992

    CAS  PubMed  Google Scholar 

  • Boehning W. Effect of cimetidine and ranitidine on plasma theophylline in patients with chronic obstructive airways disease treated with theophylline and corticosteroids. European Journal of Clinical Pharmacology 38: 43–45, 1990

    Article  CAS  PubMed  Google Scholar 

  • Boyd EJS, Penston JG, Wormsley KG. Maintenance therapy of duodenal and gastric ulcer with H2-receptor antagonists. Scandinavian Journal of Gastroenterology 25 (Suppl. 178): 72–78, 1990

    Article  Google Scholar 

  • Caballeria J. First-pass metabolism of ethanol: its role as a determinant of blood alcohol levels after drinking. Hepato-Gastroenterology 39: 62–66, 1992

    CAS  PubMed  Google Scholar 

  • Cantu TG, Korek JS. Central nervous system reactions to histamine-2 receptor blockers. Annals of Internal Medicine 144: 1027–1034, 1991

    Article  Google Scholar 

  • Cherqui B, Desaint B, Legendre C, Levy UG. Hepatite mortelle chez une patiente traitee par la ranitidine. Gastroenterologie Clinique et Biologique 13: 952–953, 1989

    CAS  PubMed  Google Scholar 

  • Das AF, Freston JW, Jacobs J, Fox NA, Morton RE. An evalation of safety in 37,252 patients treated with cimetidine or ranitidine. Internal Medicine for the Specialist 11: 3–14, 1990

    Google Scholar 

  • Dawson J, Richards DA, Stables R, Dixon GT, Cockel R. Ranitidine — pharmacology and clinical use. Journal of Clinical and Hospital Pharmacy 8: 1–13, 1983

    CAS  PubMed  Google Scholar 

  • De Angelis GL, Banchini G. Ranitidine in paediatric patients. Clinical Trials Journal 26: 370–375, 1989

    Google Scholar 

  • Del Risco FG, Rolin O, Farinotti R, Chau NP, Mourot J, et al. Influence de la ranitidine durant une periode de 24 heures sur la teneur en nitrites, nitrates, nitrosamines et sur la flore bacterienne du suc gastrique du sujet sain. Gastroenterologie Clinique et Biologique 8: 749–753, 1984

    Google Scholar 

  • DiPadova C, Roine R, Frezza M, Gentry T, Baraona E, et al. Effects of ranitidine on blood alcohol levels after ethanol ingestion. Comparison with other H2-receptor antagonists. Journal of the American Medical Association 267: 83–86, 1992

    Article  CAS  PubMed  Google Scholar 

  • Dobrilla G, De Pretis G, Piazzi L, Chilovi F, Comberlato M, et al. Is ethanol metabolism affected by oral administration of cimetidine and ranitidine at therapeutic doses? Hepato-Gastroenterology 31: 35–37, 1984

    CAS  PubMed  Google Scholar 

  • Duane PD, Shallcross TM, Heatley RV. Duodenal carcinoid tumour in a patient with rheumatoid arthritis receiving long term ranitidine treatment. British Medical Journal 300: 124–125, 1990

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Eandi M, De Carli GF, Buraglio M, Recchia G. Ranitidine: seven years of drug surveillance. Clinical Trials Journal 25: 152–157, 1988

    Google Scholar 

  • Einarson TR, Turchet EN, Goldstein JE, MacNay KR. Gout-like arthritis following cimetidine and ranitidine. Drug Intelligence and Clinical Pharmacy 19: 201–202, 1985

    Article  CAS  PubMed  Google Scholar 

  • Epstein CM. Histamine H2 antagonists and the nervous system. American Family Physician 32: 109–112, 1985

    CAS  PubMed  Google Scholar 

  • Feldman M, Burton ME. Histamine H2-receptor antagonists: Standard therapy for acid-peptic diseases. New England Journal of Medicine 323: 1672–1680, 1990

    Article  CAS  PubMed  Google Scholar 

  • Fiatarone JR, Bennett MK, Kelly P, James OFW. Ranitidine but not gastritis or female sex reduces the first pass metabolism of ethanol. Abstract. Gut 32: A 594, 1991

    Google Scholar 

  • Fraser AG, Prewett EJ, Hudson M, Sawyerr AM, Rosalki SB, et al. The effect of ranitidine, cimetidine or famotidine on low-dose post-prandial alcohol absorption. Alimentary Pharmacology and Therapeutics 5: 263–272, 1991

    Article  CAS  PubMed  Google Scholar 

  • Fraser AG, Prewett EJ, Hudson M, Sawyerr AM, Rosalki SB, et al. Ranitidine has no effect on post-prandial absorption of alcohol (0.6g/kg) after an evening meal. European Journal of Gastroenterology and Hepatology 4: 43–47, 1992a

    Google Scholar 

  • Fraser AG, Hudson M, Sawyerr AM, Rosalki SB, Pounder RE. Short report: the effect of ranitidine on the post-prandial absorption of a low dose of alcohol. Alimentary Pharmacology and Therapeutics 6: 267–271, 1992b

    Article  CAS  PubMed  Google Scholar 

  • Fraser AG, Hudson M, Sawyerr AM, Smith M, Rosalki SB, et al. Ranitidine, cimetidine, famotidine have no effect on post-prandial absorption of ethanol 0.8 g/kg taken after an evening meal. Alimentary Pharmacology and Therapeutics 6: 693–700, 1992c

    Article  CAS  PubMed  Google Scholar 

  • Fraser AG, Hudson M, Sawyerr AM, Smith MSH, Sercombe J, et al. Ranitidine has no effect on post-breakfast ethanol absorption. Americal Journal of Gastroenterology 88: 217–221, 1993

    CAS  Google Scholar 

  • Grant SM, Langtry HD, Brodgen RN. Ranitidine: an updated review of its pharmacodynamic and pharmacokinetic properties and therapeutic use in peptic ulcer disease and other allied diseases. Drugs 37: 801–870, 1989

    Article  CAS  PubMed  Google Scholar 

  • Guram M, Howden CW, Holt S. Further evidence for an interaction between alcohol and certain H2-receptor antagonists. Alcoholism: Clinical and Experimental Research 15: 1084–1085, 1991

    Article  CAS  Google Scholar 

  • Gwee MCE, Cheah LS. Actions of cimetidine and ranitidine at some cholinergic sites: implications in toxicity and anaesthesia. Life Sciences 39: 383–388, 1986

    Article  CAS  PubMed  Google Scholar 

  • Hamborg B, Kittang E, Schjonsby H. The effect of ranitidine on the absorption of food cobalamins. Scandinavian Journal of Gastroenterology 20: 756–758, 1985

    Article  CAS  PubMed  Google Scholar 

  • Hansten RD. Drug interactions with antisecretory agents. Alimentary Pharmacology and Therapeutics 5 (Suppl) 1: 121–128, 1991

    Google Scholar 

  • Hegman GW, Gilbert RP. Ranitidine-theophylline interaction — fact or fiction? Annals of Pharmacotherapy 25: 21–24, 1991

    CAS  PubMed  Google Scholar 

  • Hernandez-Munoz R, Caballeria J, Baraona E, Uppal R, Greenstein R, et al. Human gastric alcohol dehydrogenase: its inhibition by H2-receptor antagonists and its effect on the bioavailability of ethanol. Alcoholism: Clinical and Experimental Research 14: 946–950, 1990

    Article  CAS  Google Scholar 

  • Hinrichsen H, Halabi A, Kirch W. Haemodynamic effects of different H2-receptor antagonists. Clinical Pharmacology and Therapeutics 48: 302–308, 1990

    Article  CAS  PubMed  Google Scholar 

  • Holt S. Alcohol and H2 receptor antagonists: over the counter, under the table? American Journal of Gastroenterology 85: 516–517, 1990

    CAS  PubMed  Google Scholar 

  • Holt S, Howden CW. H2 antagonists and alcohol. Alimentary Pharmacology and Therapeutics 5: 666–668, 1991

    Article  CAS  PubMed  Google Scholar 

  • Hussey EK, Dukes GE. Do all histamine 2-antagonists cause a warfarin drug interaction? Annals of Pharmacotherapy 23: 675–679, 1989

    CAS  PubMed  Google Scholar 

  • Jensen DM, You S, Jensen ME, Kovacs TOG, Machicado GA, et al. Randomised controlled study of ranitidine maintenance for patients with a recent severe duodenal ulcer haemorrhage. Abstract. Gastroenterology 98: A65, 1990

    Google Scholar 

  • Juergens JP, Smith IS. Central nervous system symptoms and H2-receptor antagonists. PostMarketing Surveillance 5: 135–144, 1991

    Google Scholar 

  • Kekki M, Sipponen P, Siurala M. Progression of antral and body gastritis in patients with active and healed duodenal ulcer and duodenitis. Scandinavian Journal of Gastroenterology 19: 382–388, 1984

    CAS  PubMed  Google Scholar 

  • Kleine M, Ertl D. Comparative trial in volunteers to investigate ethanol — ranitidine interactions. Abstract. Gastroenterology 102: A98, 1992

    Google Scholar 

  • Klotz U, Kroemer HK. The drug interaction potential of ranitidine: an update. Pharmacology and Therapeutics 50: 233–244, 1991

    Article  CAS  PubMed  Google Scholar 

  • Knigge U, Thuesen B, DeJgaard A, Bennett P, Christiansen PM. Plasma concentrations of pituitary and peripheral hormones during ranitidine treatment for two years in men with duodenal ulcer. European Journal of Clinical Pharmacology 37: 305–307, 1989

    Article  CAS  PubMed  Google Scholar 

  • Kowalsky SF, Hamilton RA, Figge HL. Drug usage evaluation: H2-receptor antagonist use in 30 hospitals. Hospital Formulary 26: 725–738, 1991

    CAS  PubMed  Google Scholar 

  • Levitt MD. Review article: lack of clinical significance of the interaction between H2-receptor antagonists and ethanol. Alimentary Pharmacology and Therapeutics 7: 131–138, 1993

    Article  CAS  PubMed  Google Scholar 

  • Lewis JH. Safety profile of long-term H2-antagonist therapy. Alimentary Pharmacology and Therapeutics 5 (Suppl. 1): 49–57,1991

    PubMed  Google Scholar 

  • Martin F, Martin M. Reduction de l’acidite gastrique: consequences sur la cancerogenese gastrique induite par les N-nitrosocomposes. Gastroenterologie Clinique et Biologique 15: 102C–105C, 1991

    CAS  PubMed  Google Scholar 

  • Mignon M, Lemy T, Bonnefond A, Rusniewski P, Labeille D, et al. Development of gastric argyrophil carcinoid tumors in a case of Zollinger-Ellison syndrome with primary hyperparathyroidism during long-term anti-secretory treatment. Cancer 59: 1959–1962, 1987

    Article  CAS  PubMed  Google Scholar 

  • Miller TA. H2-receptor antagonists and blood alcohol levels. Comment. Gastroenterology 103: 1102–1103, 1992

    Article  CAS  Google Scholar 

  • Nicholson AN, Stone BM. The H2-antagonists, cimetidine and ranitidine: studies on performance. European Journal of Clinical Pharmacology 26: 579–582, 1984

    Article  CAS  PubMed  Google Scholar 

  • O’Connor RJ, Riley SE, Axon ATR, Garner RC. Effects of histamine H2-receptor antagonist (H2RA) therapy on mutagenic activity in gastric juice. Abstract. Gut 27: A608, 1986

    Google Scholar 

  • Palmer RH, Frank WO, Nambi P, Wetherington JD, Fox MJ. Effects of various concomitant medications on gastric alcohol dehydrogenase and the first-pass metabolism of ethanol. American Journal of Gastroenterology 86: 1749–1755, 1991

    CAS  PubMed  Google Scholar 

  • Penston JG. Medical events occurring in patients with duodenal ulcer disease during maintenance treatment with ranitidine. Scandinavian Journal of Gastroenterology 25 (Suppl. 177): 87–97, 1990a

    Article  Google Scholar 

  • Penston JG. Clinical assessment, gastrin concentrations, and gastric histology after 5 years of maintenance treatment with ranitidine for duodenal ulcers. Scandinavian Journal of Gastroenterology 25 (Suppl. 177): 77–86, 1990b

    Article  Google Scholar 

  • Penston JG, Wormsley KG. H2-receptor antagonists and gastric cancer. Medical Toxicology 1: 163–168, 1986a

    Article  CAS  PubMed  Google Scholar 

  • Penston JG, Wormsley KG. Adverse reactions and interactions with H2-receptor antagonists. Medical Toxicology 1: 192–216, 1986b

    Article  CAS  PubMed  Google Scholar 

  • Penston JG, Wormsley KG. Long-term maintenance treatment of gastric ulcers with ranitidine. Alimentary Pharmacology and Therapeutics 4: 339–355, 1990

    Article  CAS  PubMed  Google Scholar 

  • Penston JG, Wormsley KG. Maintenance treatment with H2-receptor antagonists for peptic ulcer disease. Alimentary Pharmacology and Therapeutics 6: 3–29, 1992a

    Article  CAS  PubMed  Google Scholar 

  • Penston JG, Wormsley KG. Nine years of maintenance treatment with ranitidine for patients with duodenal ulcer disease. Alimentary Pharmacology and Therapeutics 6: 629–645, 1992b

    Article  CAS  PubMed  Google Scholar 

  • Rao SSC, Nayak KS, Swarnalata G, Goyal DN, Rao KPP, et al. Gastric carcinoid associated with ranitidine in a patient with renal failure. American Journal of Gastroenterology 88: 1273–1274, 1993

    CAS  PubMed  Google Scholar 

  • Raufman JP, Notar-Francesco V, Raffaniello R, Straus E. Histamine H2-receptor antagonists do not alter serum ethanol levels in fed, non-alcoholic men. 57th Annual Scientific Meeting, American College of Gastroenterology 1992. Abstract 408, 1992

  • Reid CDL, Kirk A. Ranitidine fails to suppress the growth in vitro of haemopoietic progenitors from human peripheral blood or bone marrow. Human Toxicology 8: 19–22, 1989

    Article  CAS  PubMed  Google Scholar 

  • Ruszniewski P, Levy E, Mignon M. Analyse economique du traitement d’entretien de la malaide ulcereuse duodenale par la ranitidine 150 mg. Gastroenterologie Clinique et Biologique 16: 842–847, 1992

    CAS  PubMed  Google Scholar 

  • Sancho JM, Robles RG, Mancheno E, Paya C, Rodicio JL, et al. Interference by ranitidine with aldosterone secretion in vivo. European Journal of Clinical Pharmacology 27: 495–497, 1984

    Article  CAS  PubMed  Google Scholar 

  • Seitz HK, Veith S, Czygan P, Bosche J, Simon B, et al. In vivo interactions between H2-receptor antagonists and ethanol metabolism in man and in rats. Hepatology 4: 1231–1234, 1984

    Article  CAS  PubMed  Google Scholar 

  • Smith SR, Kendall MJ. Ranitidine versus cimetidine: a comparison of their potential to cause clinically important drug interactions. Clinical Pharmacokinetics 15: 44–56, 1988

    Article  CAS  PubMed  Google Scholar 

  • Theofilopoulos N, Szabadi E, Bradshaw CM. Comparison of the effects of ranitidine, cimetidine and thioridazine on psychomotor functions in healthy volunteers. British Journal of Clinical Pharmacology 18: 135–144, 1984

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Thomas JM, Misiewicz JJ, Cook AR, Hill MJ, Smith PLR, et al. Effects of one year’s treatment with ranitidine and of truncal vagotomy on gastric contents. Gut 28: 726–738

  • Toon S, Khan A, Langley S, Mullins F, Rowland M, et al. Lack of effect of high dose ranitidine on the postprandial pharmacokinetics of alcohol. Abstract. Gut 33 (Suppl. 1): S10, 1992

    Google Scholar 

  • Vial T, Goubier C, Bergeret A, Cabrera F, Evreux JCV, et al. Side effects of ranitidine. Drug Safety 6: 94–117, 1991

    Article  CAS  PubMed  Google Scholar 

  • Webster LK, Jones DB, Smallwood RA. Influence of cimetidine and ranitidine on ethanol pharmacokinetics. Australian and New Zealand Journal of Medicine 5: 359–360, 1985

    Article  Google Scholar 

  • Wormsley KG. Is hypergastrinaemia dangerous for man? Scandinavian Journal of Gastroenterology 26 (Suppl. 80): 174–178, 1991

    Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Ninewells Hospital and Medical School, Ninewells, Dundee, DD1 9SY, Scotland

    Kenneth G. Wormsley

Authors
  1. Kenneth G. Wormsley
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

About this article

Cite this article

Wormsley, K.G. Safety Profile of Ranitidine. Drugs 46, 976–985 (1993). https://doi.org/10.2165/00003495-199346060-00004

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.2165/00003495-199346060-00004

Keywords

Search

Navigation